Epoch Investment Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79M | Buy |
361,265
+31,472
| +10% | +$6.89M | 0.41% | 95 |
|
|
2025
Q1 | $73.8M | Buy |
329,793
+57,268
| +21% | +$12.8M | 0.38% | 99 |
|
|
2024
Q4 | $89.3M | Buy |
272,525
+9,981
| +4% | +$3.27M | 0.43% | 80 |
|
|
2024
Q3 | $78.8M | Sell |
262,544
-7,131
| -3% | -$2.14M | 0.35% | 113 |
|
|
2024
Q2 | $88.8M | Buy |
269,675
+9,156
| +4% | +$3.02M | 0.41% | 85 |
|
|
2024
Q1 | $103M | Buy |
260,519
+37,051
| +17% | +$14.7M | 0.46% | 74 |
|
|
2023
Q4 | $78.7M | Buy |
223,468
+99,076
| +80% | +$34.9M | 0.36% | 92 |
|
|
2023
Q3 | $46.7M | Sell |
124,392
-7,180
| -5% | -$2.69M | 0.3% | 120 |
|
|
2023
Q2 | $50.3M | Sell |
131,572
-2,842
| -2% | -$1.09M | 0.29% | 121 |
|
|
2023
Q1 | $46.6M | Sell |
134,414
-1,783
| -1% | -$618K | 0.28% | 124 |
|
|
2022
Q4 | $32.1M | Buy |
136,197
+63,185
| +87% | +$14.9M | 0.19% | 165 |
|
|
2022
Q3 | $18M | Buy |
73,012
+674
| +0.9% | +$166K | 0.12% | 201 |
|
|
2022
Q2 | $21.9M | Buy |
72,338
+855
| +1% | +$259K | 0.13% | 200 |
|
|
2022
Q1 | $29.4M | Buy |
71,483
+18,690
| +35% | +$7.68M | 0.14% | 181 |
|
|
2021
Q4 | $24.8M | Sell |
52,793
-376
| -0.7% | -$176K | 0.13% | 189 |
|
|
2021
Q3 | $22.6M | Buy |
53,169
+1,560
| +3% | +$662K | 0.13% | 193 |
|
|
2021
Q2 | $18.5M | Buy |
51,609
+873
| +2% | +$313K | 0.1% | 202 |
|
|
2021
Q1 | $14.3M | Sell |
50,736
-94
| -0.2% | -$26.5K | 0.07% | 219 |
|
|
2020
Q4 | $14.4M | Buy |
50,830
+1,816
| +4% | +$515K | 0.07% | 203 |
|
|
2020
Q3 | $13.5M | Buy |
+49,014
| New | +$13.5M | 0.07% | 195 |
|